|
Variable
|
MCI
|
AD
|
|---|
|
Off aAChEI (n = 20)
|
Ona AChEI (n = 8)
|
Off AChEI (n = 9)
|
On AChEI (n = 23)
|
|---|
|
L thalamus
|
12.25 (1.76)
|
11.91 (2.50)
|
12.96 (1.57)b
|
10.94 (1.98)
|
|
R thalamus
|
12.42 (1.64)
|
12.28 (2.62)
|
13.12 (1.53)b
|
11.17 (2.34)
|
|
L hippocampus
|
7.15 (.83)
|
7.63 (1.20)
|
7.50 (.84)b
|
5.88 (1.19)
|
|
R hippocampus
|
7.18 (.80)
|
7.44 (1.30)
|
7.34 (.82)b
|
6.14 (.93)
|
|
L caudate
|
5.92 (1.62)
|
5.16 (2.28)
|
5.40 (1.85)
|
4.46 (1.91)
|
|
R caudate
|
6.15 (1.52)
|
5.50 (1.39)
|
5.90 (1.64)
|
4.31 (2.11)
|
|
L entorhinal
|
8.55 (1.22)
|
8.51 (1.28)
|
8.51 (.87)
|
8.48 (1.77)
|
|
R entorhinal
|
10.21 (1.35)
|
10.51 (2.01)
|
10.13 (1.11)
|
9.67 (2.48)
|
|
L insula
|
8.22 (.95)
|
8.93 (1.01)
|
8.67 (1.16)
|
7.87 (1.39)
|
|
R insula
|
8.44 (.80)
|
8.95 (1.07)
|
8.72 (1.38)
|
8.00 (1.05)
|
|
L anterior cingulate
|
10.17 (1.20)
|
10.63 (1.76)
|
10.71 (1.43)
|
10.15 (1.93)
|
|
R anterior cingulate
|
10.22 (1.15)
|
10.47 (1.55)
|
10.70 (1.43)
|
9.68 (2.22)
|
- aOff and on refers to the current use of cholinesterase inhibitor medication
- bSignificant difference within the diagnostic group, p < .05
